Castle Creek Arbitrage’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-94,384
Closed -$25.1K – 16
2023
Q3
$25.1K Sell
94,384
-35,704
-27% -$11.5K 0.01% 125
2023
Q2
$46.5K Sell
130,088
-8,253
-6% -$2.52K 0.01% 184
2023
Q1
$40.1K Hold
138,341
– – ﹤0.01% 235
2022
Q4
$37.4K Hold
138,341
– – ﹤0.01% 295
2022
Q3
$62K Sell
138,341
-100
-0.1% -$59 ﹤0.01% 426
2022
Q2
$70K Sell
138,441
-16,920
-11% -$9.43K ﹤0.01% 424
2022
Q1
$95K Buy
+155,361
New +$84.7K ﹤0.01% 480

Other funds holding DRTSW

Castle Creek Arbitrage's DRTSW Position: Q4 2023 in Review

Castle Creek Arbitrage sold out of Alpha Tau Medical Warrant (DRTSW) in Q4 2023, closing a stake of 94,384 shares — an estimated $25.1K sold.

Castle Creek Arbitrage first reported a position in DRTSW in Q1 2022 and held it in 7 quarters. The position peaked at $95K in Q1 2022. 26 funds tracked by Wall St. Rank hold DRTSW as of Q4 2023.

  • Castle Creek Arbitrage reported no remaining Alpha Tau Medical Warrant position as of Q4 2023 after selling out during the quarter.
  • Castle Creek Arbitrage sold 94,384 Alpha Tau Medical Warrant shares in Q4 2023, an estimated $25.1K.
  • Castle Creek Arbitrage first reported a position in Alpha Tau Medical Warrant in Q1 2022 and held it in 7 quarters.
  • Castle Creek Arbitrage's Alpha Tau Medical Warrant position peaked at $95K in Q1 2022.
  • 26 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q4 2023.

Based on Castle Creek Arbitrage's 13F filing for Q4 2023.